Advanced search
Publication Cover
Postgraduate Medicine Volume 121, 2009 - Issue 5
Submit an article Journal homepage
69
Views
16
CrossRef citations to date
0
Altmetric
Clinical Features

Solifenacin for Overactive Bladder: Patient-Reported Outcomes from a Large Placebo-Controlled Trial

Marc R. Toglia Urogynecology Associates of Philadelphia, Media, PACorrespondence[email protected]
, MD,
Scott R. Serels Bladder Control Center of Norwalk, Norwalk, CT
, MD,
Christine Laramee Clinical Research of West Florida, Clearwater, FL
, MD,
Mickey M. Karram Advanced Urogynecology and Pelvic Surgery, Cincinnati, OH
, MD,
Indrani M. Nandy GlaxoSmithKline, Research Triangle Park, NC
, PhD,
Masakazu Andoh Formerly of Astellas Pharma US, Inc., Deerfield, IL
, ME,
Raafat Seifeldin Astellas Pharma US, Inc., Deerfield, IL
, PharmD, PhD &
Forero-Schwanhaeuser Sergio GlaxoSmithKline, King of Prussia, PA
, MD show all
Pages 151-158 | Published online: 13 Mar 2015

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Edward P. Armstrong, Daniel C. Malone & Cat N. Bui. (2012) Cost-effectiveness analysis of anti-muscarinic agents for the treatment of overactive bladder. Journal of Medical Economics 15:sup1, pages 35-44.
Read now

Articles from other publishers (15)

Akvile Stoniute, Priya Madhuvrata, Madeleine Still, Evelyn Barron-Millar, Ghulam Nabi & Muhammad Imran Omar. (2023) Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults. Cochrane Database of Systematic Reviews 2023:5.
Crossref
Hadi Mostafaei, Keiichiro Mori, Fahad Quhal, Noriyoshi Miura, Reza Sari Motlagh, Benjamin Pradere, Ekaterina Laukhtina, Ivan Lysenko, Sajjad Ghaffari, Sakineh Hajebrahimi & Shahrokh F. Shariat. (2021) Nocebo Response in the Pharmacological Management of Overactive Bladder: A Systematic Review and Meta-analysis. European Urology Focus 7:5, pages 1143-1156.
Crossref
Satabdi Chatterjee, David Walker, Tomomi Kimura & Rajender R. Aparasu. (2021) Prevalence and Factors Associated with Cumulative Anticholinergic Burden Among Older Long-Stay Nursing Home Residents with Overactive Bladder. Drugs & Aging.
Crossref
M.A. Elbaset, Diaa-Eldin Taha, Ahmed S. El-Hefnawy, Mohamad H. Zahran & A.A Shokeir. (2019) Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial. International Neurourology Journal 23:3, pages 240-248.
Crossref
Roxana Geoffrion. (2018) N o 283-Traitements visant la vessie hyperactive : Accent sur la pharmacothérapie. Journal of Obstetrics and Gynaecology Canada 40:1, pages e33-e44.
Crossref
Roxana Geoffrion. (2018) No. 283-Treatments for Overactive Bladder: Focus on Pharmacotherapy. Journal of Obstetrics and Gynaecology Canada 40:1, pages e22-e32.
Crossref
Marcus J. Drake, Sally Bowditch, Emilio Arbe, Zalmai Hakimi, Florent Guelfucci, Ikbel Amri & Jameel Nazir. (2017) A retrospective study of treatment persistence and adherence to α-blocker plus antimuscarinic combination therapies, in men with LUTS/BPH in the Netherlands. BMC Urology 17:1.
Crossref
Donald Newgreen, Brigitte Bosman, Adriana Hollestein-Havelaar, Ellen Dahler, Robin Besuyen, Will Sawyer, Stéphane Bolduc & Søren Rittig. (2017) Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical Trial. European Urology 71:3, pages 483-490.
Crossref
Roxana Geoffrion. (2016) Traitements visant la vessie hyperactive : Accent sur la pharmacothérapie. Journal of Obstetrics and Gynaecology Canada 38:12, pages S158-S170.
Crossref
Karl-Erik Andersson. 2014. Bladder Dysfunction in the Adult. Bladder Dysfunction in the Adult 121 222 .
Teresa Caballero. (2012) Efficacy Assessments in Randomized Controlled Studies of Acute Therapy for Hereditary Angioedema. Journal of Clinical Immunology 32:6, pages 1204-1212.
Crossref
Roxana Geoffrion, Danny Lovatsis, Jens-Erik Walter, Queena Chou, William Easton, Annette Epp, Roxana Geoffrion, Marie-Andrée Harvey, Annick Larochelle, Kenny Maslow, Grace Neustaedter, Dante Pascali, Marianne Pierce, Jane A. Schulz, Vyta Senikas & David Wilkie. (2012) Treatments for Overactive Bladder: Focus on Pharmacotherapy. Journal of Obstetrics and Gynaecology Canada 34:11, pages 1092-1101.
Crossref
Deyi Luo, Liangren Liu, Ping Han, Qiang Wei & Hong Shen. (2012) Solifenacin for overactive bladder: a systematic review and meta-analysis. International Urogynecology Journal 23:8, pages 983-991.
Crossref
P. Rothe, M. Kalchthaler & S. Mühlich. (2011) Therapie der überaktiven BlaseTreatment for overactive bladder. Der Urologe 50:10, pages 1301-1305.
Crossref
Marc R. Toglia, Donald R. Ostergard, Rodney A. Appell, Masakazu Andoh, Allam Fakhoury & Iqbal F. Hussain. (2010) Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status. International Urogynecology Journal 21:7, pages 847-854.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.